Regional Early Access Program Coordinator

Boehringer Ingelheim Pharmaceuticals, Inc.; Amsterdam; Hybrid; EUR 55,000 - 75,000; Full time

Benefits offered by this job

Headspace access

Hybrid work model

31 vacation days

Company pension

Wellbeing initiatives

Performance bonus

Job summary

Boehringer Ingelheim Pharmaceuticals, Inc. in Amsterdam is seeking an Early Access Treatment Coordinator (EATC) MIDI to coordinate and execute day-to-day Early Access Treatments across the MIDI region.

You will collaborate with operating units, local regulators, and clinical teams to ensure compliant, timely delivery and documentation of programs. The role emphasizes cross-functional work, local documentation localization, and safety reporting setup in collaboration with MIDI stakeholders.

Qualifications

• Bachelor or higher in Life Sciences or related field.
• Experience in Medical/Scientific operations and regulatory work.
• Knowledge of GxP and regulatory requirements.

Responsibilities

• Coordinate cross-functional activities for local EAT processes.
• Adapt global core documents to local regulations.
• Set up safety reporting with pharmacovigilance where applicable.
• Manage contract review and signature processes with centers/physicians.
• Ensure timely, compliant program execution and documentation.

Skills

Communication skills

Cross-functional collaboration

Time management

Regulatory knowledge

GxP knowledge

Stakeholder management

Self-motivated

Education

Bachelor degree in Life Sciences

Tools

Microsoft Office

Job description

Boehringer Ingelheim Pharmaceuticals, Inc. in Amsterdam is seeking an Early Access Treatment Coordinator (EATC) MIDI to coordinate and execute day-to-day Early Access Treatments across the MIDI region.

You will collaborate with operating units, local regulators, and clinical teams to ensure compliant, timely delivery and documentation of programs. The role emphasizes cross-functional work, local documentation localization, and safety reporting setup in collaboration with MIDI stakeholders.